Revise Treatment and management of obsessive-compulsive disorder for Cambridge 9990 (1.5.3)

Exposure and Response Prevention (ERP) is a highly effective behavioural therapy for OCD. It consists of two core components. The 'Exposure' part involves systematically and gradually confronting the objects, situations, or thoughts that trigger a person's obsessions and anxiety. This is often done using a 'fear hierarchy', starting with less distressing triggers. The 'Response Prevention' part involves the crucial step of refraining from engaging in the compulsive behaviours or rituals that the individual would normally use to reduce their anxiety. By resisting the compulsion, the individual learns that their anxiety will naturally decrease over time (a process called habituation) and that their feared consequences do not materialise. This breaks the cycle of obsessions and compulsions.

Cognitive Behavioural Therapy (CBT) for OCD is a broader approach that typically incorporates ERP as its central behavioural component. However, CBT adds a crucial cognitive dimension. It aims to identify, challenge, and modify the dysfunctional beliefs and cognitive distortions that underpin the obsessions. For example, a therapist might help a patient challenge 'thought-action fusion' (the belief that thinking a thought is as bad as doing it) or an inflated sense of responsibility. By restructuring these maladaptive thought patterns, the patient can reduce the distress caused by the obsessions, making it easier to engage in response prevention. CBT helps the patient become their own therapist by teaching them to question their obsessive thoughts and change their behavioural responses.

The primary biological treatment for OCD involves antidepressant medications, specifically Selective Serotonin Reuptake Inhibitors (SSRIs). This treatment is based on the serotonin hypothesis, which suggests that low levels or inefficient processing of the neurotransmitter serotonin contribute to OCD symptoms. SSRIs, such as fluoxetine or sertraline, work by blocking the reuptake of serotonin at the synapse, thereby increasing its concentration in the synaptic cleft. This enhances serotonergic neurotransmission. Patients typically require higher doses of SSRIs for OCD than for depression and may need to take them for 10-12 weeks before seeing significant improvement. While effective for many, they can have side effects and there is a risk of relapse upon discontinuation.

For moderate to severe OCD, a combined approach using both medication (SSRIs) and psychological therapy (CBT/ERP) is often recommended as the most effective treatment strategy. This synergistic approach has several benefits. SSRIs can help to reduce the intensity of the obsessive thoughts and the overwhelming anxiety, which can make a patient more receptive and able to engage with the demanding work required in CBT/ERP. The therapy then provides the patient with long-term skills to manage their thoughts and behaviours, which medication alone does not do. This combination addresses both the biological and psychological aspects of the disorder, leading to better outcomes and a lower rate of relapse compared to using either treatment in isolation.